TA
LGND icon

Teachers Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Teachers Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.75M Buy
73,296
+3,881
+6% +$294K 0.01% 1324
2018
Q4 		$5.88M Buy
69,415
+1,741
+3% +$186K 0.01% 1209
2018
Q3 		$11.6M Buy
67,674
+1,602
+2% +$242K 0.01% 1013
2018
Q2 		$8.54M Buy
66,072
+5,652
+9% +$631K 0.01% 1154
2018
Q1 		$6.22M Buy
60,420
+503
+0.8% +$49.7K 0.01% 1224
2017
Q4 		$5.12M Buy
59,917
+489
+0.8% +$42.4K 0.01% 1335
2017
Q3 		$5.05M Buy
59,428
+64
+0.1% +$5.07K 0.01% 1325
2017
Q2 		$4.5M Buy
59,364
+6,746
+13% +$472K 0.01% 1373
2017
Q1 		$3.47M Buy
52,618
+2,656
+5% +$175K 0.01% 1489
2016
Q4 		$3.17M Sell
49,962
-183,893
-79% -$11.6M 0.01% 1527
2016
Q3 		$14.9M Buy
233,855
+68,719
+42% +$5.05M 0.02% 746
2016
Q2 		$12.3M Buy
165,136
+3,847
+2% +$285K 0.02% 781
2016
Q1 		$10.8M Buy
161,289
+120,066
+291% +$7.3M 0.02% 833
2015
Q4 		$2.79M Buy
41,223
+694
+2% +$42.8K 0.01% 1400
2015
Q3 		$2.17M Sell
40,529
-872
-2% -$52.9K ﹤0.01% 1531
2015
Q2 		$2.61M Sell
41,401
-5,350
-11% -$292K ﹤0.01% 1517
2015
Q1 		$2.25M Hold
46,751
– – ﹤0.01% 1580
2014
Q4 		$1.55M Hold
46,751
– – ﹤0.01% 1784
2014
Q3 		$1.37M Sell
46,751
-263,686
-85% -$8.75M ﹤0.01% 1829
2014
Q2 		$12.1M Buy
310,437
+59,508
+24% +$2.41M 0.02% 789
2014
Q1 		$10.5M Buy
250,929
+82,867
+49% +$3.45M 0.02% 794
2013
Q4 		$5.51M Buy
168,062
+129,048
+331% +$4.2M 0.01% 1045
2013
Q3 		$1.05M Buy
39,014
+933
+2% +$26.2K ﹤0.01% 1895
2013
Q2 		$889K Buy
+38,081
New +$685K ﹤0.01% 1923

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Teachers Advisors's LGND Position: Q1 2019 in Review

Teachers Advisors increased its Ligand Pharmaceuticals (LGND) stake by 5.6% in Q1 2019, buying an estimated $294K and bringing the position to 73,296 shares worth $5.75M. The position accounts for 0.01% of the portfolio, ranked #1324.

Teachers Advisors first reported a position in LGND in Q2 2013 and has held it in 24 quarters since. The position peaked at $14.9M in Q3 2016. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • Teachers Advisors held 73,296 shares of Ligand Pharmaceuticals worth $5.75M as of Q1 2019.
  • Teachers Advisors bought 3,881 Ligand Pharmaceuticals shares in Q1 2019, an estimated $294K.
  • Ligand Pharmaceuticals made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1324 holding.
  • Teachers Advisors first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Ligand Pharmaceuticals position peaked at $14.9M in Q3 2016.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.